Literature DB >> 8077938

Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon).

L Z Xu1, D Larzul, E Delaporte, C Bréchot, D Kremsdorf.   

Abstract

Following a survey of hepatitis C virus (HCV) infection recently carried in central Africa (Gabon), we cloned and sequenced PCR products of the 5' non-coding and capsid-encoding regions of HCV RNA from three randomly selected HCV RNA-positive Gabonese subjects. In the capsid-encoding region, the identity between the three Gabonese isolates was 91 to 98%. The three Gabonese sequences showed a divergence of 11 to 17% from published HCV genotypes I to IV (1a, 1b, 2a and 2b) isolates and of 6 to 11% from HCV genotype 4 isolates. Thus the Gabonese isolates, termed HC-G, belong to HCV genotype 4. Based on the sequences of the three isolates, a specific probe (cpsG) was designed to detect the HC-G genotype in 30 randomly selected anti-HCV-positive Gabonese subjects, 14 of whom were HCV RNA-positive. Analysis with cpsG showed that 10 of 14 of the HCV RNA-positive subjects were infected by the HC-G genotype. HC-G is therefore highly prevalent in the HCV RNA-positive Gabonese population. The availability of these Gabonese sequences should facilitate the design of specific serological tests for African HCV isolates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077938     DOI: 10.1099/0022-1317-75-9-2393

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

2.  Predominance of hepatitis C virus genotype 1b in Bulgaria.

Authors:  A Andonov; P Teoharov; S Bakalova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 3.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 4.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 5.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

6.  Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin.

Authors:  Waleed Al-Hamoudi; Hazem Mohamed; Faisal Abaalkhail; Yaser Kamel; Nasser Al-Masri; Naglaa Allam; Saleh Alqahtani; Mohammed Al-Sofayan; Hatem Khalaf; Mohammed Al-Sebayel; Ahmed Al-Jedai; Ayman Abdo
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

7.  Detection of hepatitis C virus and antibodies in postmortem blood and bloodstains.

Authors:  Tomokazu Takasaka; Yoshito Itoh; Hiroto Kaneko; Hiroshi Ikegaya
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

8.  Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t.

Authors:  Chunhua Li; Ling Lu; Xianghong Wu; Chuanxi Wang; Phil Bennett; Teng Lu; Donald Murphy
Journal:  J Gen Virol       Date:  2009-04-08       Impact factor: 3.891

9.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

10.  Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China.

Authors:  Y Y Zhang; A S Lok; D T Chan; A Widell
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.